Populations enriched for myogenic progenitors are obtained by selection on
the basis of expression of specific cell surface markers. The muscle
progenitor cells are characterized as being CD45.sup.- and CD34.sup.+,
and may further be characterized as lacking expression of Mac-1 (CD11b)
and positive for expression of CXCR4 (CD184) and .beta.1-integrin (CD29).